| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8217870 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 5 Pages |
Abstract
Use of the CMLB for APBI delivery is associated with acceptable long-term local control and toxicity. Local recurrence-free survival was 97.8% at 3Â years. Significant (grade 3) toxicity was uncommon, and no grade 4 toxicity was observed. Treatment at high-volume centers was associated with decreased late toxicity.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Laurie W. MD, Douglas W. MD, Frank MD, Dorin PhD, Thomas MD, Nitai PhD,